JP2002531522A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531522A5 JP2002531522A5 JP2000586362A JP2000586362A JP2002531522A5 JP 2002531522 A5 JP2002531522 A5 JP 2002531522A5 JP 2000586362 A JP2000586362 A JP 2000586362A JP 2000586362 A JP2000586362 A JP 2000586362A JP 2002531522 A5 JP2002531522 A5 JP 2002531522A5
- Authority
- JP
- Japan
- Prior art keywords
- pcrv
- composition
- pseudomonas aeruginosa
- antigen
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 description 9
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 208000032536 Pseudomonas Infections Diseases 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 108010025813 Pseudomonas antigen V Proteins 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10995298P | 1998-11-25 | 1998-11-25 | |
| US60/109,952 | 1998-11-25 | ||
| US12679499P | 1999-03-30 | 1999-03-30 | |
| US60/126,794 | 1999-03-30 | ||
| PCT/US1999/027796 WO2000033872A2 (en) | 1998-11-25 | 1999-11-23 | Method of and compositions for immunization with the pseudomonas v antigen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273433A Division JP2011068672A (ja) | 1998-11-25 | 2010-12-08 | シュードモナス・アエルギノーザ感染を診断するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002531522A JP2002531522A (ja) | 2002-09-24 |
| JP2002531522A5 true JP2002531522A5 (enExample) | 2007-01-25 |
| JP4707234B2 JP4707234B2 (ja) | 2011-06-22 |
Family
ID=26807543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586362A Expired - Fee Related JP4707234B2 (ja) | 1998-11-25 | 1999-11-23 | シュードモナスｖ抗原を用いる免疫化のための組成物 |
| JP2010273433A Ceased JP2011068672A (ja) | 1998-11-25 | 2010-12-08 | シュードモナス・アエルギノーザ感染を診断するための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273433A Ceased JP2011068672A (ja) | 1998-11-25 | 2010-12-08 | シュードモナス・アエルギノーザ感染を診断するための組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6309651B1 (enExample) |
| EP (2) | EP1049488B1 (enExample) |
| JP (2) | JP4707234B2 (enExample) |
| AT (2) | ATE318613T1 (enExample) |
| AU (1) | AU3580800A (enExample) |
| CA (1) | CA2318536C (enExample) |
| DE (1) | DE69930166T2 (enExample) |
| DK (1) | DK1049488T3 (enExample) |
| ES (2) | ES2255329T3 (enExample) |
| WO (1) | WO2000033872A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002064161A2 (en) * | 2001-01-26 | 2002-08-22 | Mcw Research Foundation, Inc. | Method and compositions for immunization with the pseudomonas v antigen |
| AU2007231760B2 (en) * | 2001-01-26 | 2009-10-29 | Mcw Research Foundation, Inc. | Method and compositions for immunization with the pseudomonas V antigen |
| EP1425300A2 (de) * | 2001-09-13 | 2004-06-09 | Medizinische Hochschule Hannover | Phaenotyp bestimmende virulenzgene von pseudomonas aeruginosa zur kolonisation und persistenz in mensch, tier und pflanze, verwendungen der gene und zugehoerige proteine |
| WO2003058205A2 (en) * | 2002-01-11 | 2003-07-17 | Cornell Research Foundation, Inc. | Methods of identifying putative effector proteins |
| KR20110124375A (ko) | 2002-08-13 | 2011-11-16 | 햅토젠 리미티드 | 항-락톤 또는 락톤 유도된 시그널 분자 항체를 이용한 감염성 세균 질환의 치료 방법 |
| AU2005207003C1 (en) * | 2004-01-20 | 2013-06-13 | Humanigen, Inc. | Antibody specificity transfer using minimal essential binding determinants |
| GB0407008D0 (en) | 2004-03-27 | 2004-04-28 | Haptogen Ltd | Methods for inducing rapid cell death (autolysis) in infectious bacteria |
| GB0410958D0 (en) | 2004-05-15 | 2004-06-16 | Haptogen Ltd | Methods for reducing biofilm formation in infectious bacteria |
| AU2006307018B2 (en) | 2005-10-28 | 2012-10-25 | Meiji Seika Kaisha, Ltd. | Outer coat protein PA5158 of Pseudomonas aeruginosa |
| US8084044B2 (en) | 2006-03-30 | 2011-12-27 | Meiji Seika Kaisha, Ltd. | Pseudomonas aeruginosa outer membrane protein PA0427 |
| US20100330100A1 (en) * | 2007-06-29 | 2010-12-30 | Meiji Seika Kaisha Ltd. | Pseudomonas aeruginosa-outer membrane protein pa4710 |
| SG186017A1 (en) | 2007-11-30 | 2012-12-28 | Kalobios Pharmaceuticals Inc | Antibodies to the pcrv antigen of pseudomonas aeruginosa |
| AU2008342152B2 (en) | 2007-12-25 | 2013-06-27 | Meiji Seika Pharma Co., Ltd. | Component protein PA1698 for type-III secretion system of Pseudomonas aeruginosa |
| EP2599792A1 (en) * | 2008-01-10 | 2013-06-05 | Shionogi&Co., Ltd. | Antibody directed against PcrV |
| EP2393515A1 (en) | 2009-02-04 | 2011-12-14 | Kalobios Pharmaceuticals, Inc. | Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection |
| SG174225A1 (en) | 2009-03-11 | 2011-10-28 | Shionogi & Co | Humanized pcrv antibody having anti-pseudomonal activity |
| EP2515935A4 (en) * | 2009-12-22 | 2013-08-28 | Kalobios Pharmaceuticals Inc | METHOD FOR TREATING STAPHYLOCOCCUS INFECTION IN A PATIENT WITH PSEUDOMONAS AERUGINOSA INFECTION WITH LOW PATHOGEN LEVEL |
| EP2726103B1 (en) * | 2011-07-01 | 2018-09-05 | The Trustees Of The University Of Pennsylvania | Anti-properdin antibodies and uses thereof |
| AU2012336028A1 (en) | 2011-11-07 | 2014-06-26 | Medimmune, Llc | Combination therapies using anti- Pseudomonas Psl and PcrV binding molecules |
| EP2904014A4 (en) | 2012-10-04 | 2016-09-28 | Novelmed Therapeutics Inc | FOR ALTERNATIVE PATHS, SPECIFIC ANTIBODIES FOR THE TREATMENT OF HEMOLYTIC DISEASES |
| CN110028559B (zh) * | 2019-04-15 | 2022-06-10 | 中国人民解放军陆军军医大学 | 一种铜绿假单胞菌疫苗重组蛋白及其编码基因和它们的应用 |
| WO2021031270A1 (zh) * | 2019-08-22 | 2021-02-25 | 四川大学 | 细菌膜囊泡及其分离制备系统和方法 |
| EP4069312A4 (en) * | 2019-12-04 | 2024-03-27 | The Research Foundation for the State University of New York | COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF ANTIBODY-DRUG CONJUGATES |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3178014B2 (ja) * | 1991-07-05 | 2001-06-18 | 東ソー株式会社 | Ｒｎａの測定方法 |
| US5599665A (en) * | 1993-12-21 | 1997-02-04 | Mcw Research Foundation | Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection |
-
1999
- 1999-11-23 ES ES99971223T patent/ES2255329T3/es not_active Expired - Lifetime
- 1999-11-23 AU AU35808/00A patent/AU3580800A/en not_active Abandoned
- 1999-11-23 DE DE69930166T patent/DE69930166T2/de not_active Expired - Lifetime
- 1999-11-23 CA CA002318536A patent/CA2318536C/en not_active Expired - Fee Related
- 1999-11-23 EP EP99971223A patent/EP1049488B1/en not_active Expired - Lifetime
- 1999-11-23 EP EP06000111A patent/EP1666058B1/en not_active Expired - Lifetime
- 1999-11-23 DK DK99971223T patent/DK1049488T3/da active
- 1999-11-23 JP JP2000586362A patent/JP4707234B2/ja not_active Expired - Fee Related
- 1999-11-23 AT AT99971223T patent/ATE318613T1/de not_active IP Right Cessation
- 1999-11-23 WO PCT/US1999/027796 patent/WO2000033872A2/en not_active Ceased
- 1999-11-23 ES ES06000111T patent/ES2379801T3/es not_active Expired - Lifetime
- 1999-11-23 US US09/448,339 patent/US6309651B1/en not_active Expired - Lifetime
- 1999-11-23 AT AT06000111T patent/ATE539349T1/de active
-
2001
- 2001-01-26 US US09/770,916 patent/US6827935B2/en not_active Expired - Lifetime
-
2010
- 2010-12-08 JP JP2010273433A patent/JP2011068672A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531522A5 (enExample) | ||
| CA2318536A1 (en) | Method of and compositions for immunization with the pseudomonas v antigen | |
| JP2004511201A5 (enExample) | ||
| JP2010532657A5 (enExample) | ||
| WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
| WO2001021810B1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JPH07504565A (ja) | ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質 | |
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JPH07506573A (ja) | プロテインｌおよびそのハイブリッドプロテイン類 | |
| JP2004504808A5 (enExample) | ||
| WO2001021804B1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| EP0826774A3 (en) | Staphylococcal Fab I enoyl-ACP reductase | |
| CA2195090A1 (en) | Lkp pilin structural genes and operon of nontypable haemophilus influenzae | |
| FR2771751A1 (fr) | Erythrovirus et ses applications | |
| AU2005203173B2 (en) | Super-antigen fusion proteins and the use thereof | |
| EP2172214A3 (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
| CA2190359A1 (en) | Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection | |
| CA2323751A1 (en) | Diagnostics and vaccines for mycobacterial infections of animals and humans | |
| NZ520600A (en) | Novel therapeutic compositions for treating infection by Lawsonia spp | |
| EP1749833A1 (en) | Super-antigens derived from the SARS coronavirus E2 spike protein | |
| ATE435915T1 (de) | Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria | |
| JP2002514891A (ja) | ヘリコバクター・ピロリからの分泌性遺伝子を同定する方法 | |
| CN114164214A (zh) | 一种基于crispr技术检测病原微生物的方法 | |
| CN1318646A (zh) | 编码伤寒沙门氏菌特异性和抗原性外膜蛋白的dna序列 | |
| EP0839910A3 (en) | Spo-rel, a Staphylococcus relA/spot homologue |